Dulaglutide
Drug timelines are a Plus or Pro feature.
35 regulatory and trial events tracked for Dulaglutide, covering 2014-10-07 to 2026-07-08. Get the full timeline:
Most recent: Clinical Trial Results: A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes [Phase 3]